Skip to main content
Sackler School of Graduate Biomedical Sciences

Bachovchin Partnership May Stimulate New Drug Development

Friday, July 27, 2018
New biotech partnership involving Sackler faculty member Bill Bachovchin to advance development of new drugs.
lab experiment

The developer of Affimer biotherapeutics and reagents, Avacta Group, has agreed to a co-development partnership with Bach BioSciences, a company that commercializes the research of Bill Bachovchin from Tufts University School of Medicine and the Sackler School.

Read the full story.